OncoCyte (OCX) Earnings Date, Estimates & Call Transcripts → Revolutionizing the Green Energy Space and Building Shareholder Value Along the Way (From Small Cap Sniper) (Ad) Free OCX Stock Alerts $2.90 +0.01 (+0.35%) (As of 03:54 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueOCX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.OCX Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Monetary GoldTrump Reveals Conspiracy Behind Fed-Controlled Digital Currency.Donald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans are implemented, it could mean the end of America as we know it.This means you must act NOW before it's too late. OncoCyte Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:($2.91) EPSOCX Earnings Date and InformationOncoCyte has confirmed that its next quarterly earnings report will be published on Wednesday, May 15th, 2024. OncoCyte will be holding an earnings conference call on Wednesday, May 15th at 4:30 PM Eastern. Interested parties can register for or listen to the call. or dial in at 646-307-1963 with passcode "4153469". Read More Get OncoCyte Earnings AlertsEnter your email address below to receive the latest news and earnings results for OCX and its competitors with MarketBeat's FREE daily newsletter. OncoCyte Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/15/2024Confirmed)------- 11/9/2023Q3 2023($1.52)($0.57)+$0.95($0.33)$0.40 million$0.43 million8/10/2023Q2 2023($2.60)($1.07)+$1.53($1.07)$0.60 million$0.46 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($2.00)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($2.00)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($2.00)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million Get the Latest News and Ratings for OCX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for OncoCyte and its competitors with MarketBeat's FREE daily newsletter. 5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 millionDemocrats Push to Replace Dollar With Digital Coin, Control Currency. (Ad)Donald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans are implemented, it could mean the end of America as we know it.This means you must act NOW before it's too late.5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($1.60)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($1.60)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($1.60)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($1.40)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($1.40)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($1.40)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 millionGuard Against the Coming Financial Upheaval (Ad)America’s Most Shocking Financial Story… Behind closed doors in D.C., there is a dark political and economic plot underway. That’s why if you have any savings in the bank or own any assets you want to protect, you must watch this new documentary before it’s too late.You can stream it for free right here. 8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million 5/11/2022Q1 2022($2.60)($2.20)+$0.40($2.20)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($2.20)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($2.20)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 millionAmerica could fall from this event (Ad)America’s “Internal Enemies” Exposed New documentary exposes a hidden election plan in Washington D.C. that, if successful, could be more financially and culturally devastating than the dot-com blowup of 2000, the 2008 financial crisis, or the COVID crash.Click here to see how you can protect yourself today. 5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million 3/10/2022Q4 2021($2.00)($2.40)($0.40)$3.00$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$3.00$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$3.00$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 millionLook Who Fired the World’s Richest Man (Ad)This company is tiny… but already has contracts with 30 federal agencies and services some of the biggest companies in the U.S. And demand for the technology is unprecedented … “unlike anything we have seen in the past,” says a spokesman.Get the full story here.3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million 11/9/2021Q3 2021($1.40)($2.60)($1.20)($2.20)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($2.20)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($2.20)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($2.40)($3.00)($0.60)($0.11)$3.20 million$0.98 million 8/10/2021Q2 2021($1.60)($2.20)($0.60)($2.00)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($2.00)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($2.00)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/9/2021Q2 2021($2.00)($2.40)($0.40)($0.10)$1.65 million$2.03 million 5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.60)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.60)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.60)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/16/2021Q1 2021($2.00)($1.00)+$1.00($0.03)$0.91 million$1.12 million OncoCyte Earnings - Frequently Asked Questions When is OncoCyte's earnings date? OncoCyte has confirmed that its next quarterly earnings data will be published on Wednesday, May 15th, 2024. Learn more on OCX's earnings history. How much revenue does OncoCyte generate each year? OncoCyte (NASDAQ:OCX) has a recorded annual revenue of $1.50 million. How much profit does OncoCyte generate each year? OncoCyte (NASDAQ:OCX) has a recorded net income of -$27.78 million. OCX has generated $0.00 earnings per share over the last four quarters. More Earnings Resources from MarketBeat Related Companies: CDIO Earnings TRIB Earnings ACHL Earnings BMRA Earnings AWH Earnings DRRX Earnings MYMD Earnings ICCC Earnings ABIO Earnings VNRX Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Home Depot: Earnings Mixed, Wait to Buy the DipTraders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong Earnings This page (NASDAQ:OCX) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperInvest Now: Starpax's Cancer Breakthrough Achieving What Others Haven't for a CenturyStarpaxDid Intel Just Dethrone Nvidia?Chaikin AnalyticsDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldThis 1 Biotech Stock has been shocking the marketsHuge AlertsHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportAmerica’s worst nightmare?Porter & CompanyHow to Make 100X on the AI BoomInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OncoCyte Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
